Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
Kaunitz
Andrew M
AM
University of Florida Health Science Center/Jacksonville, USA.
D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control; D000075202:Contraindications; D004334:Drug Administration Schedule; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D010353:Patient Education as Topic; D017698:Postmenopause; D045167:Progesterone Congeners / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D016387:Women's Health
D004966:Estrogens, Conjugated (USP); D045167:Progesterone Congeners; D017258:Medroxyprogesterone Acetate